Docusign Inc. (NASDAQ:DOCU - Get Free Report) insider Robert Chatwani sold 13,817 shares of the company's stock in a transaction that occurred on Wednesday, September 17th. The shares were sold at an average price of $83.10, for a total value of $1,148,192.70. Following the sale, the insider owned 71,162 shares in the company, valued at approximately $5,913,562.20. This trade represents a 16.26% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Robert Chatwani also recently made the following trade(s):
- On Monday, September 15th, Robert Chatwani sold 1,682 shares of Docusign stock. The shares were sold at an average price of $80.30, for a total transaction of $135,064.60.
- On Thursday, September 11th, Robert Chatwani sold 983 shares of Docusign stock. The shares were sold at an average price of $79.39, for a total transaction of $78,040.37.
Docusign Trading Up 3.4%
Shares of DOCU traded up $2.81 during trading hours on Wednesday, reaching $84.52. 3,773,556 shares of the company traded hands, compared to its average volume of 3,212,079. The firm has a market cap of $17.00 billion, a price-to-earnings ratio of 61.90, a PEG ratio of 4.28 and a beta of 1.02. Docusign Inc. has a 12-month low of $55.14 and a 12-month high of $107.86. The stock's fifty day moving average price is $75.99 and its 200 day moving average price is $79.26.
Docusign (NASDAQ:DOCU - Get Free Report) last released its quarterly earnings data on Thursday, September 4th. The company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.84 by $0.08. The firm had revenue of $800.64 million during the quarter, compared to the consensus estimate of $780.35 million. Docusign had a return on equity of 14.01% and a net margin of 9.08%.The firm's quarterly revenue was up 8.8% on a year-over-year basis. During the same period in the previous year, the company posted $0.97 earnings per share. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. On average, research analysts forecast that Docusign Inc. will post 1.17 earnings per share for the current year.
Docusign declared that its Board of Directors has initiated a share buyback program on Thursday, June 5th that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the company to reacquire up to 6.6% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company's board of directors believes its stock is undervalued.
Hedge Funds Weigh In On Docusign
Several large investors have recently bought and sold shares of DOCU. New Age Alpha Advisors LLC lifted its position in Docusign by 738.2% in the first quarter. New Age Alpha Advisors LLC now owns 41,187 shares of the company's stock valued at $3,353,000 after purchasing an additional 36,273 shares during the period. Pinpoint Asset Management Ltd lifted its position in shares of Docusign by 54.3% during the 1st quarter. Pinpoint Asset Management Ltd now owns 56,985 shares of the company's stock valued at $4,639,000 after acquiring an additional 20,043 shares during the period. Concurrent Investment Advisors LLC acquired a new stake in shares of Docusign during the 1st quarter valued at approximately $618,000. Gilman Hill Asset Management LLC lifted its position in shares of Docusign by 4.9% during the 1st quarter. Gilman Hill Asset Management LLC now owns 84,326 shares of the company's stock valued at $6,864,000 after acquiring an additional 3,904 shares during the period. Finally, Blair William & Co. IL lifted its position in shares of Docusign by 1.7% during the 1st quarter. Blair William & Co. IL now owns 387,542 shares of the company's stock valued at $31,546,000 after acquiring an additional 6,460 shares during the period. Institutional investors and hedge funds own 77.64% of the company's stock.
Wall Street Analysts Forecast Growth
DOCU has been the subject of several recent analyst reports. Robert W. Baird lifted their price target on Docusign from $85.00 to $90.00 and gave the company a "neutral" rating in a research note on Friday, September 5th. Zacks Research upgraded Docusign from a "hold" rating to a "strong-buy" rating in a report on Tuesday, September 9th. Piper Sandler upped their price target on Docusign from $85.00 to $90.00 and gave the stock a "neutral" rating in a research note on Friday, September 5th. UBS Group set a $95.00 price target on Docusign in a research note on Friday, September 5th. Finally, Wedbush decreased their price target on Docusign from $100.00 to $85.00 and set a "neutral" rating on the stock in a research note on Thursday, June 12th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and fourteen have issued a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $94.14.
Check Out Our Latest Analysis on Docusign
About Docusign
(
Get Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Docusign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.
While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.